Coverage
-
November 10, 2016
A New Jersey federal judge gave final approval Thursday to a $3.3 million settlement in a proposed class action over claims that Roka Bioscience concealed facts surrounding problems with its testing system for foodborne pathogens before its $60 million initial public offering.
2 other articles on this case.
View all »